Marksans Pharma Ltd. logo

Marksans Pharma Ltd. (MARKSANS)

Market Closed
12 Dec, 22:00
MSE MSE
193. 95
+2.35
+1.23%
- Market Cap
- P/E Ratio
2% Div Yield
58,612 Volume
- Eps
191.6
Previous Close
Day Range
191.4 195
Year Range
162.05 332.2
Want to track MARKSANS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 57 days
Name Time Cons. EPS Eps
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
9 Feb 2026 (In 1 month)
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
10 Nov 2025
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
11 Aug 2025
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
11 Feb 2025
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
7 Nov 2024
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
27 Aug 2024
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
9 Aug 2024
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
28 May 2024
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
13 Feb 2024
-
-
Marksans Pharma Ltd. logo
MARKSANS Marksans Pharma Ltd.
9 Nov 2023
-
-

MARKSANS Earnings Reports FAQ

What is the earnings per share (EPS) for MARKSANS?

EPS data for MARKSANS is currently not available, as Marksans Pharma Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Over the past 11 years, the earnings growth rate has been approximately 20.61%, reflecting the MARKSANS's performance and MSE market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-09, based on the MARKSANS's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 2.1681 per share, reported on 2025-11-10. For dividend history, visit the MARKSANS Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 89.46, calculated based on the most recent stock price of ₹193.95.